Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05024045
Title Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

B-cell lymphoma

Therapies

LOXO-305 + LOXO-338

LOXO-338

Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.